Attributes | Values |
---|
rdf:type
| |
http://linked.open...gbank/description
| - Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière's disease. It is also commonly used for patients with balance disorders. (en)
|
http://linked.open...generalReferences
| - # "Health Canada":http://webprod.hc-sc.gc.ca/dpd-bdpp/info.do?lang=eng&code=76587 (en)
|
http://linked.open...gy/drugbank/group
| |
http://linked.open...drugbank/halfLife
| |
http://linked.open...ugbank/indication
| - For the reduction of episodes of vertigo association with Ménière's disease. (en)
|
sameAs
| |
Title
| |
adms:identifier
| |
http://linked.open...outeOfElimination
| |
http://linked.open.../drugbank/synonym
| - 2-(beta-Methylaminoethyl)pyridine (en)
- 2-[2-(Methylamino)ethyl]pyridine (en)
- Betahistina (en)
- Betahistinum (en)
- N-Methyl-2-(2-pyridinyl)ethanamine (en)
- N-Methyl-2-pyridineethanamine (en)
- [2-(2-Pyridyl)ethyl]methylamine (en)
|
http://linked.open...drugbank/toxicity
| - Symptoms of overdose (< 640 mg) include mild to moderate nausea, dry mouth, dyspepsia, abdominal pain and somnolence. More serious complications such as convulsions, pulmonary or cardiac complications, may occur with higher intentional overdoses (> 640 mg). (en)
|
http://linked.open.../drug/hasAHFSCode
| |
http://linked.open...k/foodInteraction
| |
http://linked.open...nk/proteinBinding
| |
http://linked.open...ynthesisReference
| - Jean S. Cherqui, Alain C. Djiane, "New galenical form of administration of betahistine and its derivatives and the preparation thereof." U.S. Patent US4264574, issued February, 1979. (en)
|
http://linked.open...ugbank/IUPAC-Name
| |
http://linked.open...gy/drugbank/InChI
| |
http://linked.open...Molecular-Formula
| |
http://linked.open.../Molecular-Weight
| |
http://linked.open...noisotopic-Weight
| |
http://linked.open...y/drugbank/SMILES
| |
http://linked.open.../Water-Solubility
| |
http://linked.open...ogy/drugbank/logP
| |
http://linked.open...ogy/drugbank/logS
| |
http://linked.open...logy/drugbank/pKa
| |
http://linked.open...l/drug/hasATCCode
| |
http://linked.open...nd-Acceptor-Count
| |
http://linked.open...-Bond-Donor-Count
| |
http://linked.open...drugbank/InChIKey
| |
http://linked.open...urface-Area--PSA-
| |
http://linked.open...nk/Polarizability
| |
http://linked.open...bank/Refractivity
| |
http://linked.open...atable-Bond-Count
| |
http://linked.open...ugbank/absorption
| - When given orally, betahistine is rapidly absorbed from the gastrointestinal tract. (en)
|
http://linked.open.../affectedOrganism
| - Humans and other mammals (en)
|
http://linked.open...casRegistryNumber
| |
http://linked.open...drugbank/category
| |
http://linked.open...k/Bioavailability
| |
http://linked.open...bank/Ghose-Filter
| |
http://linked.open...nk/MDDR-Like-Rule
| |
http://linked.open...k/Number-of-Rings
| |
http://linked.open...siological-Charge
| |
http://linked.open...bank/Rule-of-Five
| |
http://linked.open...tional-IUPAC-Name
| |
http://linked.open...-strongest-basic-
| |